# Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

> **NCT00002647** · PHASE1 · UNKNOWN · sponsor: **Medical College of Wisconsin** · enrollment: 24 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors
- Metastatic Cancer

## Interventions

- **DRUG:** verteporfin
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00002647
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1994-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002647, "Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00002647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*